ArticlePrzeglad gastroenterologiczny2026
The role of endoscopic biliary drainage in access to systemic chemotherapy in patients with malignant biliary obstruction.
Article in Przeglad gastroenterologiczny, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Endoscopic drainage is the standard of care in patients with malignant biliary obstruction (MBO). Aim: The aim of this study was to investigate the efficacy of biliary stenting in providing access to systemic chemotherapy. Material and methods: Patients with bile duct obstruction (bilirubin > 2.5 mg/dl) caused by unresectable biliary or pancreatic cancer were retrospectively analysed with respect to use of chemotherapy and survival. Laboratory data were analysed at baseline, 7-10, and 28-35 days following biliary stenting. Results: Patients with MBO ( Conclusions: In two-thirds of patients with MBO, endoscopic biliary drainage does not secure access to chemotherapy. The use of chemotherapy and survival time are significantly higher in patients with a bilirubin level below 15 mg/dl as compared to those with higher bilirubinaemia, but biliary drainage is only minimally effective in patients with a bilirubin level below 6 mg/dl.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.